PTGS2 and prostate carcinoma: EGCG from green tea was described to attenuate the AR, to downregulate IGF-1, to modulate COX-2 expression, and to decrease MAPK signaling leading to the reduction in cell proliferation and induction of apoptosis in prostate cancer without toxicity [164].